SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056193
Filing Date
2021-11-10
Accepted
2021-11-10 16:11:29
Documents
72
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q itos-10q_20210930.htm   iXBRL 10-Q 3266638
2 EX-31.1 itos-ex311_7.htm EX-31.1 18400
3 EX-31.2 itos-ex312_8.htm EX-31.2 22697
4 EX-32.1 itos-ex321_9.htm EX-32.1 12248
  Complete submission text file 0001564590-21-056193.txt   9732806

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA itos-20210930.xsd EX-101.SCH 63869
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itos-20210930_cal.xml EX-101.CAL 50236
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itos-20210930_def.xml EX-101.DEF 211866
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE itos-20210930_lab.xml EX-101.LAB 437421
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itos-20210930_pre.xml EX-101.PRE 350847
10 EXTRACTED XBRL INSTANCE DOCUMENT itos-10q_20210930_htm.xml XML 1638865
Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39401 | Film No.: 211396695
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences